Indegene provided payer insights across multiple countries for a fully integrated US biopharmaceutical company launching a solid oral product in a competitive disease state with high unmet needs. The company sought to optimize PRMA through drug pricing insights, assess net price strategy impacts, and identify resonant payer messages. Indegene's advanced software leveraged proprietary payer panels of 100+ US and 30 EU experts to model pricing scenarios, analyze reimbursement dynamics, and simulate strategy outcomes. This drove better margins, refined messaging, and ensured competitive launch success.

Join for free to read